Loading clinical trials...
Loading clinical trials...
A Placebo Controlled, Double-blind, Multi-centre, Single Dose, Parallel Group, Randomised Clinical Trial of GSK2862277 in Patients Undergoing Oesophagectomy Surgery
Conditions
Interventions
GSK2862277
Placebo
Locations
6
United Kingdom
GSK Investigational Site
Cottingham, Yorkshire, United Kingdom
GSK Investigational Site
Belfast, United Kingdom
GSK Investigational Site
Birmingham, United Kingdom
GSK Investigational Site
Birmingham, United Kingdom
GSK Investigational Site
Cambridge, United Kingdom
GSK Investigational Site
Middlesbrough, United Kingdom
Start Date
April 28, 2015
Primary Completion Date
June 28, 2017
Completion Date
June 28, 2017
Last Updated
October 27, 2020
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions